Chamaida H. Plasencia

La Paz, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease-modifying antirheumatic drugs: results from the BIOBADASER III registry.

Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease-modifying antirheumatic drugs: results from the BIOBADASER III registry.

Journal: Rheumatology (Oxford, England)

Published: July 22, 2025

Can we identify axial spondyloarthritis among young adults referred to non-rheumatology specialists? Results from the SHERPAS study.

Can we identify axial spondyloarthritis among young adults referred to non-rheumatology specialists? Results from the SHERPAS study.

Journal: Seminars in arthritis and rheumatism

Published: March 15, 2025

Pathogenic mechanisms involving the interplay between adipose tissue and auto-antibodies in rheumatoid arthritis.

Pathogenic mechanisms involving the interplay between adipose tissue and auto-antibodies in rheumatoid arthritis.

Journal: iScience

Published: March 07, 2022

Comment on: Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization.

Comment on: Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization.

Journal: Rheumatology advances in practice

Published: April 16, 2021

Doppler enthesitis: a potential useful outcome in the assessment of axial spondyloarthritis and psoriatic arthritis.

Doppler enthesitis: a potential useful outcome in the assessment of axial spondyloarthritis and psoriatic arthritis.

Journal: Clinical rheumatology

Published: July 13, 2020

Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis.

Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis.

Journal: Arthritis research & therapy

Published: April 27, 2020

False positives in the ultrasound diagnosis of giant cell arteritis: some diseases can also show the halo sign.

False positives in the ultrasound diagnosis of giant cell arteritis: some diseases can also show the halo sign.

Journal: Rheumatology (Oxford, England)

Published: July 15, 2019

Cost evolution of biological drugs in rheumatoid arthritis patients in a tertiary hospital: Influential factors on price.

Cost evolution of biological drugs in rheumatoid arthritis patients in a tertiary hospital: Influential factors on price.

Journal: Reumatologia clinica

Published: May 14, 2019

Cost evolution of biological agents for the treatment of spondyloarthritis in a tertiary hospital: influential factors in price.

Cost evolution of biological agents for the treatment of spondyloarthritis in a tertiary hospital: influential factors in price.

Journal: International journal of clinical pharmacy

Published: December 26, 2017

Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis.

Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis.

Journal: Therapeutic drug monitoring

Published: July 13, 2017

Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Spondyloarthritis.

Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Spondyloarthritis.

Journal: Therapeutic drug monitoring

Published: April 06, 2017

Color Doppler and spectral Doppler ultrasound detection of active sacroiliitis in spondyloarthritis compared to physical examination as gold standard.

Color Doppler and spectral Doppler ultrasound detection of active sacroiliitis in spondyloarthritis compared to physical examination as gold standard.

Journal: Rheumatology international

Published: March 08, 2017

Showing 1-12 of 26

Last Updated: 09/26/2026